STERIS (STE)
Supplies sterilization equipment, procedural products, and services for healthcare and life-sciences workflows.
$208.79
After hours+0.04 (+0.02%)
At close$208.75(+0.86%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Sep 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,238 | 1,298 | 1,116 | 1,280 | 1,329 | 1,371 | 1,481 | 1,391 | 1,460 | 1,496 | 1,588 | 1,493 |
| Cost of revenue | 692 | 738 | 668 | 707 | 750 | 760 | 839 | 763 | 814 | 841 | 891 | 809 |
| Gross profit | 546 | 560 | 449 | 572 | 579 | 610 | 641 | 628 | 646 | 656 | 697 | 684 |
| 355 | 334 | 203 | 387 | 359 | 365 | 425 | 382 | 380 | 382 | 381 | 398 | |
| Research & development | 26 | 25 | 25 | 26 | 27 | 27 | 28 | 26 | 28 | 30 | 29 | 29 |
| Selling, general & administrative | 328 | 308 | 152 | 336 | 329 | 335 | 334 | 354 | 350 | 352 | 352 | 0 |
| Other expenses | 0 | 0 | 26 | 26 | 3 | 2 | 63 | 2 | 2 | 0 | 0 | 370 |
| Operating income | 192 | 226 | 245 | 186 | 220 | 245 | 216 | 246 | 268 | 271 | 317 | 286 |
| −36 | −37 | −30 | −10 | −25 | −17 | −19 | −14 | −15 | −13 | −12 | −12 | |
| Interest income | 1 | 2 | 6 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 0 | 0 |
| Interest expense | 37 | 39 | 36 | 30 | 20 | 19 | 17 | 16 | 15 | 15 | 15 | 16 |
| Other non-operating income | −1 | −2 | −6 | −20 | 5 | −3 | 2 | −2 | 1 | 2 | −3 | 4 |
| Income before tax | 156 | 190 | 215 | 175 | 195 | 229 | 197 | 232 | 253 | 258 | 305 | 274 |
| Income tax expense | 35 | 41 | 43 | 35 | 44 | 55 | 50 | 54 | 61 | 64 | 84 | 73 |
| Net income from continuing operations | 121 | 149 | 172 | 140 | 151 | 173 | 147 | 178 | 193 | 194 | 220 | 201 |
| Discontinued operations | −4 | −8 | 0 | 6 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 |
| Other adjustments | 0 | 0 | −173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 115 | 141 | −1 | 145 | 150 | 174 | 146 | 177 | 192 | 193 | 220 | 200 |
| EPS, basic | $1.17 | $1.42 | −$0.01 | $1.47 | $1.52 | $1.76 | $1.48 | $1.80 | $1.95 | $1.96 | $2.24 | $2.05 |
| EPS, diluted | $1.16 | $1.42 | −$0.01 | $1.46 | $1.51 | $1.75 | $1.48 | $1.79 | $1.94 | $1.96 | $2.24 | $2.04 |
| Weighted average shares, basic | 99 | 99 | 99 | 99 | 99 | 98 | 98 | 98 | 98 | 98 | 98 | 98 |
| Weighted average shares, diluted | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | 98 | 98 |
| EBITDA | 345 | 369 | 386 | 318 | 330 | 374 | 337 | 367 | 390 | 391 | 680 | 349 |
| Depreciation & amortization | 152 | 141 | 134 | 113 | 115 | 126 | 122 | 119 | 122 | 122 | 361 | 67 |
| EBIT | 193 | 229 | 252 | 206 | 215 | 248 | 214 | 248 | 268 | 269 | 320 | 282 |
